4//SEC Filing
DALE STEPHEN 4
Accession 0001209191-23-005744
CIK 0001422143other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:10 PM ET
Size
7.1 KB
Accession
0001209191-23-005744
Insider Transaction Report
Form 4
DALE STEPHEN
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-01-27$13.89/sh−4,385$60,909→ 32,515 total - Sale
Common Stock
2023-01-27$13.87/sh−4,840$67,124→ 27,675 total
Footnotes (3)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
- [F2]This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2022.
- [F3]This transaction was executed in multiple trades at prices ranging from $13.62 to $14.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001821709
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:10 PM ET
- Size
- 7.1 KB